Mediastinal fibrosis and mirtazapin
Published on May 28, 2011in Revue de Médecine Interne0.783
· DOI :10.1016/J.REVMED.2010.08.012
We report a 61-year-old woman who developed a superior vena cava syndrome due to mediastinal fibrosis. This mediastinal fibrosis resolved after the discontinuation of a chronic treatment by mirtazapin that the patient was receiving for the previous six years, suggesting a role of this treatment in the genesis of the mediastinal fibrosis.